SAPA-GP Hosted the Third @Philly Cell and Gene Therapy Annual Conference
2024年6月18日 - 8:07PM
ビジネスワイヤ(英語)
On June 14-15, SAPA-GP held the 2024 @Philly Cell and Gene
Therapy Annual Conference at the Sheraton Valley Forge Hotel in
King of Prussia, northwest of Philadelphia. Over 500 life
scientists, pharmaceutical professionals, entrepreneurs, investors,
and senior executives attended the conference. Inaugurated in 2022,
the annual conference has become a leading platform in the region
to showcase the latest developments in cell, gene, and RNA
therapies, and to connect biotech entrepreneurs with investors.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240617792223/en/
Keynote speech by Dr. Peter Marks (Photo:
Business Wire)
Dr. Yufeng Li, the conference co-chair and president of SAPA-GP,
opened the conference. Dr. Peter Marks, Director of the Center for
Biologics Evaluation and Research (CBER) at the FDA, delivered a
keynote speech on advancing the development of novel biologic
products. He was followed by a keynote address from Dr. Jason Bock,
CEO of CTMC, on accelerating cell therapy transformation. The
second day of the conference was opened by Dr. Haichen Yang, the
conference co-founder and former president of SAPA-GP (2022-2023).
Dr. Guangping Gao, Professor of UMass Chan Medical School and a key
pioneer of gene therapy, and Dr. P.J. Brooks, a world-renowned NIH
researcher in rare diseases, gave keynote addresses on AAV gene
therapy for CNS diseases and novel platform approaches to genetic
therapies and rare disease clinical trials.
For two days, over seventy accomplished scientists, biopharma
professionals, investors, entrepreneurs, as well as other movers
and shakers delivered presentations, panel talks, and one-on-one
discussions in five parallel tracks. The @Philly forum, partnered
with the Chamber of Commerce for Greater Philadelphia, highlighted
Greater Philadelphia’s thriving biotech ecosystem in R&D,
manufacturing, and entrepreneurship.
“Great to see the conference’s increasing influence and
contribution to the Greater Philadelphia area's biotech ecosystem,”
commented Dr. Yufeng Li, president of SAPA-GP.
The 2025 @Philly Cell and Gene Therapy Annual Conference will be
held in June 2025. For more information about programs and
sponsoring opportunities at SAPA-GP, please visit
https://sapagp.org/.
About SAPA-GP
Founded in 2002, SAPA’s mission is to promote pharmaceutical
sciences and biotechnology, facilitate scientific and business
cooperation, and foster career development of pharmaceutical
professionals. Each year SAPA-GP hosts many conferences and events
in science, business, investment, and career development. With over
4,000 members, SAPA-GP has been instrumental in shaping favorable
biotech ecosystems in Greater Philadelphia.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240617792223/en/
Bill Lu bill.lu@sapa-gp.org